Uri Ahn, MD
Orthopaedic Surgery of the Spine · Bedford, NHNPI 1053303313
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $471,127 of the $472,542 with a category attached, or 99.7%. Osseus Fusion Systems, LLC accounts for 85.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $122,177 and has fallen 68.7% since, to $38,237 in 2025.
Across 97 payments — averaging $4871.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Osseus Fusion Systems, LLC$403K
- Alphatec Spine, Inc$69K
- AbbVie$195
- Medtronic$188
- Abbott$162
- Stryker$71
- plus $296 from 8 others
What the payments were for
- Royalty or licence$471,127100%
- Food & beverage$1,4150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Osseus Fusion Systems, LLC | 38 | $402,741 |
| Alphatec Spine, Inc | 33 | $68,890 |
| AbbVie | 6 | $195 |
| Medtronic | 4 | $188 |
| Abbott | 4 | $162 |
| Stryker | 1 | $71 |
| Johnson & Johnson | 1 | $55 |
| Boston Scientific | 3 | $52 |
| Globus Medical | 1 | $47 |
| Lifenet Health | 2 | $40 |
| Cerapedics Inc. | 1 | $33 |
| Biocomposites Inc | 1 | $30 |
| Radius Health, Inc. | 1 | $22 |
| Smith+Nephew | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Solus ALIF$34,439
- LIF$11,760
- Aspida Plaltes & Screw$10,227
- Other - Miscellaneous$9,542
- Aspida$2,702
How this compares
Too few orthopaedic surgery of the spine providers in New Hampshireto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 114 | $1,121 |
| Gabapentin | 47 | $382 |
| Diclofenac Potassium | 30 | $361 |
| Tramadol Hcl | 38 | $170 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $128 |
| Meloxicam | 17 | $105 |
| Oxycodone Hcl | 11 | $100 |
| Methylprednisolone | 15 | $98 |
| Diazepam | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Bedford
- Adrian ThomasBedford$944K
- Thomas KleemanBedford$398K
- Gary FleischerNashua$747K
- Kevin McGuireLebanon$153K
- Russell Brummett IiConcord$2K
- Peter DirksmeierSomersworth$907
- William AbduLebanon$23
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.